Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 252

1.

Takayasu arteritis: an update

Keser G, Aksu K, Direskeneli H.

Turk J Med Sci. 2018 Aug 16;48(4):681-697. doi: 10.3906/sag-1804-136.

PMID:
30114347
2.

Certolizumab pegol in the treatment of Takayasu arteritis.

Novikov PI, Smitienko IO, Sokolova MV, Alibaz-Oner F, Kaymaz-Tahra S, Direskeneli H, Moiseev SV.

Rheumatology (Oxford). 2018 Jul 12. doi: 10.1093/rheumatology/key197. [Epub ahead of print]

PMID:
30010945
3.

Management of vascular Behçet's disease.

Alibaz-Oner F, Direskeneli H.

Int J Rheum Dis. 2018 Apr 17. doi: 10.1111/1756-185X.13298. [Epub ahead of print] No abstract available.

PMID:
29665281
4.

Impaired cardiac and vascular motion in patients with Takayasu's arteritis: A velocity vector imaging-based study.

Yurdakul S, Alibaz-Öner F, Direskeneli H, Aytekin S.

Eur J Rheumatol. 2018 Mar;5(1):16-21. doi: 10.5152/eurjrheum.2017.16108. Epub 2017 Oct 25.

5.

Management of Behçet's disease.

Alibaz-Oner F, Sawalha AH, Direskeneli H.

Curr Opin Rheumatol. 2018 May;30(3):238-242. doi: 10.1097/BOR.0000000000000497.

PMID:
29432223
6.

EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice.

Dejaco C, Ramiro S, Duftner C, Besson FL, Bley TA, Blockmans D, Brouwer E, Cimmino MA, Clark E, Dasgupta B, Diamantopoulos AP, Direskeneli H, Iagnocco A, Klink T, Neill L, Ponte C, Salvarani C, Slart RHJA, Whitlock M, Schmidt WA.

Ann Rheum Dis. 2018 May;77(5):636-643. doi: 10.1136/annrheumdis-2017-212649. Epub 2018 Jan 22.

7.

A genome-wide association study identifies nucleotide variants at SIGLEC5 and DEFA1A3 as risk loci for periodontitis.

Munz M, Willenborg C, Richter GM, Jockel-Schneider Y, Graetz C, Staufenbiel I, Wellmann J, Berger K, Krone B, Hoffmann P, van der Velde N, Uitterlinden AG, de Groot LCPGM, Sawalha AH, Direskeneli H, Saruhan-Direskeneli G, Guzeldemir-Akcakanat E, Keceli HG, Laudes M, Noack B, Teumer A, Holtfreter B, Kocher T, Eickholz P, Meyle J, Doerfer C, Bruckmann C, Lieb W, Franke A, Schreiber S, Nohutcu RM, Erdmann J, Loos BG, Jepsen S, Dommisch H, Schaefer AS.

Hum Mol Genet. 2018 Mar 1;27(5):941-942. doi: 10.1093/hmg/ddy015. No abstract available.

PMID:
29346566
8.

Comparison of early versus late onset familial Mediterranean fever.

Yasar Bilge NS, Sari I, Solmaz D, Senel S, Emmungil H, Kilic L, Yilmaz Oner S, Yildiz F, Yilmaz S, Ersozlu Bozkirli D, Aydin Tufan M, Yilmaz S, Yazisiz V, Pehlivan Y, Bes C, Yildirim Cetin G, Erten S, Gonullu E, Sahin F, Akar S, Aksu K, Kalyoncu U, Direskeneli H, Erken E, Sayarlioglu M, Cınar M, Kasifoglu T.

Int J Rheum Dis. 2018 Apr;21(4):880-884. doi: 10.1111/1756-185X.13259. Epub 2018 Jan 5.

PMID:
29314707
9.

Increased stiffness of median nerve in systemic sclerosis.

Yagci I, Kenis-Coskun O, Ozsoy T, Ozen G, Direskeneli H.

BMC Musculoskelet Disord. 2017 Nov 7;18(1):434. doi: 10.1186/s12891-017-1793-9.

10.

Nationwide Experience With Off-Label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever Patients.

Akar S, Cetin P, Kalyoncu U, Karadag O, Sari I, Cınar M, Yilmaz S, Onat AM, Kisacik B, Erden A, Balkarli A, Kucuksahin O, Oner SY, Senel S, Tufan A, Direskeneli H, Oksuz F, Pehlivan Y, Bayindir O, Keser G, Aksu K, Omma A, Kasifoglu T, Unal AU, Yildiz F, Balci MA, Yavuz S, Erten S, Ozgen M, Sayarlıoglu M, Dogru A, Yildirim G, Oner FA, Tezcan ME, Pamuk ON, Onen F.

Arthritis Care Res (Hoboken). 2018 Jul;70(7):1090-1094. doi: 10.1002/acr.23446. Epub 2018 Apr 24.

PMID:
28992387
11.

Health-related outcomes of importance to patients with Takayasu's arteritis.

Sreih AG, Alibaz-Oner F, Easley E, Davis T, Mumcu G, Milman N, Robson J, Direskeneli H, Merkel PA, Cronholm P.

Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):51-57. Epub 2017 Sep 18.

12.

Discrepancies between vascular and systemic inflammation in large vessel vasculitis: an important problem revisited.

Keser G, Aksu K, Direskeneli H.

Rheumatology (Oxford). 2018 May 1;57(5):784-790. doi: 10.1093/rheumatology/kex333. Review.

PMID:
28968895
13.

Assessment of the frequency of cardiovascular risk factors in patients with Takayasu's arteritis.

Alibaz-Oner F, Koster MJ, Unal AU, Yildirim HG, Çikikçi C, Schmidt J, Crowson CS, Makol A, Ytterberg SR, Matteson EL, Direskeneli H, Warrington KJ.

Rheumatology (Oxford). 2017 Nov 1;56(11):1939-1944. doi: 10.1093/rheumatology/kex300.

PMID:
28968808
14.

An update on the role of epigenetics in systemic vasculitis.

Coit P, Direskeneli H, Sawalha AH.

Curr Opin Rheumatol. 2018 Jan;30(1):4-15. doi: 10.1097/BOR.0000000000000451. Review.

PMID:
28957963
15.

Could Sublingual Immunotherapy Affect Oral Health in Children with Asthma and/or Allergic Rhinitis Sensitized to House Dust Mite?

Kiykim A, Mumcu G, Ogulur I, Karakoc-Aydiner E, Direskeneli H, Baris S, Cagan H, Ozen A.

Int Arch Allergy Immunol. 2017;174(1):52-56. doi: 10.1159/000480082. Epub 2017 Sep 27.

PMID:
28950285
16.

OMERACT Endorsement of Patient-reported Outcome Instruments in Antineutrophil Cytoplasmic Antibody-associated Vasculitis.

Robson JC, Tomasson G, Milman N, Ashdown S, Boonen A, Casey GC, Cronholm PF, Cuthbertson D, Dawson J, Direskeneli H, Easley E, Kermani TA, Farrar JT, Gebhart D, Lanier G, Luqmani RA, Mahr A, McAlear CA, Peck J, Shea B, Shea JA, Sreih AG, Tugwell PS, Merkel PA.

J Rheumatol. 2017 Oct;44(10):1529-1535. doi: 10.3899/jrheum.161139. Epub 2017 Sep 1.

17.

Assessment of Disease Activity in Large-vessel Vasculitis: Results of an International Delphi Exercise.

Aydin SZ, Direskeneli H, Merkel PA; International Delphi on Disease Activity Assessment in Large-vessel Vasculitis.

J Rheumatol. 2017 Dec;44(12):1928-1932. doi: 10.3899/jrheum.161269. Epub 2017 Sep 1.

PMID:
28864648
18.

Development of a Core Set of Outcome Measures for Large-vessel Vasculitis: Report from OMERACT 2016.

Sreih AG, Alibaz-Oner F, Kermani TA, Aydin SZ, Cronholm PF, Davis T, Easley E, Gul A, Mahr A, McAlear CA, Milman N, Robson JC, Tomasson G, Direskeneli H, Merkel PA.

J Rheumatol. 2017 Dec;44(12):1933-1937. doi: 10.3899/jrheum.161467. Epub 2017 Sep 1.

PMID:
28864646
19.

Takayasu's arteritis: A new era is approaching.

Direskeneli H.

Presse Med. 2017 Jul - Aug;46(7-8 Pt 2):e177. doi: 10.1016/j.lpm.2017.08.006. No abstract available.

PMID:
28843640
20.

Outcomes of Patients with Behçet's Syndrome after Pulmonary Endarterectomy.

Yıldızeli ŞO, Yanartaş M, Taş S, Direskeneli H, Mutlu B, Ceyhan B, Yıldızeli B.

Thorac Cardiovasc Surg. 2018 Mar;66(2):187-192. doi: 10.1055/s-0037-1604411. Epub 2017 Aug 15.

PMID:
28810271
21.

Patient-reported outcomes in Takayasu's arteritis.

Alibaz-Oner F, Sreih AG, Merkel PA, Direskeneli H.

Presse Med. 2017 Jul - Aug;46(7-8 Pt 2):e225-e227. doi: 10.1016/j.lpm.2017.03.023. Epub 2017 Jul 26.

PMID:
28756078
22.

Long-Term Efficacy of Pegylated Interferon Alpha-2b in Behçet's Uveitis: A Small Case Series.

Celiker H, Kazokoglu H, Direskeneli H.

Ocul Immunol Inflamm. 2017 Jul 12:1-8. doi: 10.1080/09273948.2017.1332768. [Epub ahead of print]

PMID:
28700247
23.

Oral ulcer activity in Behcet's disease: Poor medication adherence is an underestimated risk factor.

Mumcu G, Alibaz-Öner F, Öner SY, Özen G, Atagündüz P, İnanç N, Köksal L, Ergun T, Direskeneli H.

Eur J Rheumatol. 2017 Jun;4(2):109-112. doi: 10.5152/eurjrheum.2017.160094. Epub 2017 Jun 1.

24.

A genome-wide association study identifies nucleotide variants at SIGLEC5 and DEFA1A3 as risk loci for periodontitis.

Munz M, Willenborg C, Richter GM, Jockel-Schneider Y, Graetz C, Staufenbiel I, Wellmann J, Berger K, Krone B, Hoffmann P, van der Velde N, Uitterlinden AG, de Groot LCPGM, Sawalha AH, Direskeneli H, Saruhan-Direskeneli G, Guzeldemir-Akcakanat E, Keceli HG, Laudes M, Noack B, Teumer A, Holtfreter B, Kocher T, Eickholz P, Meyle J, Doerfer C, Bruckmann C, Lieb W, Franke A, Schreiber S, Nohutcu RM, Erdmann J, Loos BG, Jepsen S, Dommisch H, Schaefer AS.

Hum Mol Genet. 2017 Jul 1;26(13):2577-2588. doi: 10.1093/hmg/ddx151.

PMID:
28449029
25.

Reply to: Behçet's disease: an MHC-I-opathy?

McGonagle D, Aydin SZ, Gül A, Mahr A, Direskeneli H.

Clin Exp Rheumatol. 2017 May-Jun;35 Suppl 104(2):6. Epub 2017 Apr 14. No abstract available.

26.

Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease.

Deniz R, Tulunay-Virlan A, Ture Ozdemir F, Unal AU, Ozen G, Alibaz-Oner F, Aydin-Tatli I, Mumcu G, Ergun T, Direskeneli H.

Immunol Invest. 2017 Jul;46(5):518-525. doi: 10.1080/08820139.2017.1306865. Epub 2017 Apr 17.

PMID:
28414558
27.

Association of ERAP1, IL23R and PTGER4 Polymorphisms with Radiographic Severity of Ankylosing Spondylitis.

Ozen G, Deniz R, Eren F, Erzik C, Unal AU, Yavuz S, Aydin SZ, Inanc N, Direskeneli H, Atagunduz P.

Open Rheumatol J. 2017 Jan 16;11:1-9. doi: 10.2174/1874312901711010001. eCollection 2017.

28.

Corrigendum: Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy.

Carmona FD, Coit P, Saruhan-Direskeneli G, Hernández-Rodríguez J, Cid MC, Solans R, Castañeda S, Vaglio A, Direskeneli H, Merkel PA, Boiardi L, Salvarani C, González-Gay MA, Martín J, Sawalha AH; Spanish GCA Study Group; Italian GCA Study Group; Turkish Takayasu Study Group; Vasculitis Clinical Research Consortium.

Sci Rep. 2017 Apr 5;7:46012. doi: 10.1038/srep46012. No abstract available.

29.

Reply to: Assessing the role of pentraxin-3 in Takayasu's arteritis. De Luca G. et al.

Alibaz-Oner F, Direskeneli H.

Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):222. Epub 2017 Mar 31. No abstract available.

PMID:
28375839
30.

Clinical assessment in Takayasu's arteritis: major challenges and controversies.

Direskeneli H.

Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):189-193. Epub 2017 Mar 27. Review.

PMID:
28375833
31.

Developing a Core Set of Outcome Measures for Behçet Disease: Report from OMERACT 2016.

Hatemi G, Meara A, Ozguler Y, Direskeneli H, Mahr A, Easley E, Gurcan M, Davis T, Gul A, Yazici Y, Zottenberg K, Esatoglu SN, Erer B, Kamali S, Yazici H, Cronholm PF, Merkel PA.

J Rheumatol. 2017 Nov;44(11):1750-1753. doi: 10.3899/jrheum.161352. Epub 2017 Apr 1.

PMID:
28365574
32.

Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy.

Carmona FD, Coit P, Saruhan-Direskeneli G, Hernández-Rodríguez J, Cid MC, Solans R, Castañeda S, Vaglio A, Direskeneli H, Merkel PA, Boiardi L, Salvarani C, González-Gay MA, Martín J, Sawalha AH; Spanish GCA Study Group; Italian GCA Study Group; Turkish Takayasu Study Group; Vasculitis Clinical Research Consortium.

Sci Rep. 2017 Mar 9;7:43953. doi: 10.1038/srep43953.

33.

Immune and inflammatory gene expressions are different in Behçet's disease compared to those in Familial Mediterranean Fever.

Özdemir FT, Demiralp EE, Aydın SZ, Atagündüz P, Ergun T, Direskeneli H.

Eur J Rheumatol. 2016 Dec;3(4):146-152. doi: 10.5152/eurjrheum.2016.15099. Epub 2016 Dec 1.

34.

Remarkable damage along with poor quality of life in Takayasu arteritis: cross-sectional results of a long-term followed-up multicentre cohort.

Omma A, Erer B, Karadag O, Yilmaz N, Alibaz-Oner F, Yildiz F, Kalfa M, Kimyon G, Kiraz S, Direskeneli H, Erken E, Aksu K, Onat AM, Gül A, Ocal L, Inanc M, Kamali S.

Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):77-82. Epub 2016 Nov 10.

PMID:
27908308
35.

Infliximab-induced cutaneous eruption resembling pityriasis rubra pilaris in a patient with Takayasu's arteritis.

Salman A, Sonmez Y, Sahin H, Unal AU, Direskeneli H, Cinel L, Ergun T.

Dermatol Ther. 2017 May;30(3). doi: 10.1111/dth.12443. Epub 2016 Nov 12. No abstract available.

PMID:
27862745
36.

Severe neuro-Behcet's disease treated with a combination of immunosuppressives and a TNF-inhibitor.

Korkmaz FN, Ozen G, Ünal AU, Kahraman Koytak P, Tuncer N, Direskeneli H.

Acta Reumatol Port. 2016 Oct-Dec;41(4):367-371.

37.

Direct and indirect healthcare costs of rheumatoid arthritis patients in Turkey.

Hamuryudan V, Direskeneli H, Ertenli I, Inanc M, Karaaslan Y, Oksel F, Ozbek S, Pay S, Terzioglu E, Balkan Tezer D, Hacibedel B, Akkoc N.

Clin Exp Rheumatol. 2016 Nov-Dec;34(6):1033-1037. Epub 2016 Sep 18.

PMID:
27749224
38.

Current antiviral practice and course of Hepatitis B virus infection in inflammatory arthritis: a multicentric observational study (A + HBV study).

Kalyoncu U, Emmungil H, Onat AM, Yılmaz S, Kaşifoglu T, Akar S, İnanç N, Yıldız F, Küçükşahin O, Karadağ Ö, Mercan R, Bes C, Yazısız V, Yılmazer B, Özmen M, Erten Ş, Şenel S, Yazıcı A, Taşçılar K, Kalfa M, Kiraz S, Kısacık B, Pehlivan Y, Kılıç L, Şimşek İ, Çefle A, Akkoç N, Direskeneli H, Erken E, Turgay M, Öztürk MA, Soy M, Aksu K, Dinç A, Ertenli İ.

Eur J Rheumatol. 2015 Dec;2(4):149-154. Epub 2015 Dec 1.

39.

Fatigue in systemic lupus erythematosus : Association with disease activity, quality of life and psychosocial factors.

Yilmaz-Oner S, Ilhan B, Can M, Alibaz-Oner F, Polat-Korkmaz O, Ozen G, Mumcu G, Kremers HM, Tuglular S, Direskeneli H.

Z Rheumatol. 2017 Dec;76(10):913-919. doi: 10.1007/s00393-016-0185-0.

PMID:
27600110
40.

Post-thrombotic syndrome and venous disease-specific quality of life in patients with vascular Behçet's disease.

Alibaz-Oner F, Aldag B, Aldag M, Unal AU, Mutiş A, Toptas T, Ergun T, Direskeneli H.

J Vasc Surg Venous Lymphat Disord. 2016 Jul;4(3):301-6. doi: 10.1016/j.jvsv.2016.01.003. Epub 2016 Mar 2.

PMID:
27318049
41.

Sequencing of 16S rRNA reveals a distinct salivary microbiome signature in Behçet's disease.

Coit P, Mumcu G, Ture-Ozdemir F, Unal AU, Alpar U, Bostanci N, Ergun T, Direskeneli H, Sawalha AH.

Clin Immunol. 2016 Aug;169:28-35. doi: 10.1016/j.clim.2016.06.002. Epub 2016 Jun 7.

PMID:
27283393
42.

Analysis of Systemic Sclerosis-associated Genes in a Turkish Population.

Carmona FD, Onat AM, Fernández-Aranguren T, Serrano-Fernández A, Robledo G, Direskeneli H, Sawalha AH, Yavuz S, Martín J.

J Rheumatol. 2016 Jul;43(7):1376-9. doi: 10.3899/jrheum.160045. Epub 2016 May 1.

PMID:
27134258
43.

Risk factors for malignancy in systemic sclerosis patients.

Kaşifoğlu T, Yaşar Bilge Ş, Yıldız F, Özen G, Pehlivan Y, Yılmaz N, Tarhan F, Yılmaz S, Küçük A, Emmungil H, Koca SS, Çınar M, Direskeneli H, Erken E, Can G, Özmen M, Gönüllü E, Kisacik B, Aksu K, Karadağ O, Kasifoglu N, Arslantas D, Sahin F, Keser G, Yavuz S, Birlik M, Onat AM.

Clin Rheumatol. 2016 Jun;35(6):1529-33. doi: 10.1007/s10067-016-3288-8. Epub 2016 Apr 27.

PMID:
27118199
44.

Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still's disease: Data from a large multicenter cohort.

Kalyoncu U, Solmaz D, Emmungil H, Yazici A, Kasifoglu T, Kimyon G, Balkarli A, Bes C, Ozmen M, Alibaz-Oner F, Erten S, Cagatay Y, Cetin GY, Yilmaz S, Yildiz F, Pamuk ON, Kucuksahin O, Kilic L, Yazisiz V, Karadag O, Koca SS, Hayran M, Akar S, Aksu K, Akkoc N, Keser G, Gonullu E, Kisacik B, Onat AM, Soy M, Inanc N, Direskeneli H, Sayarlioglu M, Erken E, Turgay M, Cefle A, Ertenli I, Pay S.

J Autoimmun. 2016 May;69:59-63. doi: 10.1016/j.jaut.2016.02.010. Epub 2016 Mar 9.

PMID:
26970681
45.

The epidemiology of Takayasu arteritis: a hospital-based study from northwestern part of Turkey.

Saritas F, Donmez S, Direskeneli H, Pamuk ON.

Rheumatol Int. 2016 Jul;36(7):911-6. doi: 10.1007/s00296-016-3445-z. Epub 2016 Mar 2. Review.

PMID:
26936260
46.

Fatigue in patients with Behcet's syndrome: relationship with quality of life, depression, anxiety, disability and disease activity.

Ilhan B, Can M, Alibaz-Oner F, Yilmaz-Oner S, Polat-Korkmaz O, Ozen G, Mumcu G, Maradit Kremers H, Direskeneli H.

Int J Rheum Dis. 2016 Feb 23. doi: 10.1111/1756-185X.12839. [Epub ahead of print]

PMID:
26913703
47.

Plasma pentraxin-3 levels in patients with Takayasu's arteritis during routine follow-up.

Alibaz-Oner F, Aksu K, Yentur SP, Keser G, Saruhan-Direskeneli G, Direskeneli H.

Clin Exp Rheumatol. 2016 May-Jun;34(3 Suppl 97):S73-6. Epub 2016 Feb 5.

PMID:
26885720
48.

Subclinical Atherosclerosis in Systemic Sclerosis: Not Less Frequent Than Rheumatoid Arthritis and Not Detected With Cardiovascular Risk Indices.

Ozen G, Inanc N, Unal AU, Korkmaz F, Sunbul M, Ozmen M, Akar S, Deniz R, Donmez S, Pamuk ON, Atagunduz P, Tigen K, Direskeneli H.

Arthritis Care Res (Hoboken). 2016 Oct;68(10):1538-46. doi: 10.1002/acr.22852. Epub 2016 Sep 2.

49.

Assessment of the New 2012 EULAR/ACR Clinical Classification Criteria for Polymyalgia Rheumatica: A Prospective Multicenter Study.

Ozen G, Inanc N, Unal AU, Bas S, Kimyon G, Kisacik B, Onat AM, Murat S, Keskin H, Can M, Mengi A, Cakir N, Balkarli A, Cobankara V, Yilmaz N, Yazici A, Dogru A, Sahin M, Sahin A, Gok K, Senel S, Pamuk ON, Yilmaz S, Bayindir O, Aksu K, Cagatay Y, Akyol L, Sayarlioglu M, Yildirim-Cetin G, Yasar-Bilge S, Yagci I, Aydin SZ, Alibaz-Oner F, Atagunduz P, Direskeneli H.

J Rheumatol. 2016 May;43(5):893-900. doi: 10.3899/jrheum.151103. Epub 2016 Feb 1.

PMID:
26834222
50.

Characteristics Predicting Tuberculosis Risk under Tumor Necrosis Factor-α Inhibitors: Report from a Large Multicenter Cohort with High Background Prevalence.

Kisacik B, Pamuk ON, Onat AM, Erer SB, Hatemi G, Ozguler Y, Pehlivan Y, Kilic L, Ertenli I, Can M, Direskeneli H, Keser G, Oksel F, Dalkilic E, Yilmaz S, Pay S, Balkarli A, Cobankara V, Cetin GY, Sayarlioglu M, Cefle A, Yazici A, Avci AB, Terzioglu E, Ozbek S, Akar S, Gul A.

J Rheumatol. 2016 Mar;43(3):524-9. doi: 10.3899/jrheum.150177. Epub 2016 Jan 15.

PMID:
26773107

Supplemental Content

Loading ...
Support Center